Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Location status: Recruiting
Location contact
Barry Borlaug, MD
CONTACT
Barry Borlaug, MD
PRINCIPAL_INVESTIGATOR
Dr. Borlaug's Research Team
CONTACT
NCT Number: NCT07401771
The purpose of this study is to internally validate low-field Ex-CMR as a noninvasive tool for diagnosing, phenotyping, and risk stratifying HFpEF in patients with exertional dyspnea.
Interested in participating?
Request Info18 year–80 year
All sexes
Observational
Rochester, Minnesota, 55905, United States
Location status: Recruiting
Barry Borlaug, MD
CONTACT
Barry Borlaug, MD
PRINCIPAL_INVESTIGATOR
Dr. Borlaug's Research Team
CONTACT
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Exercise Cardiovascular Magnetic Resonance is a non-invasive imaging technique that combines cardiovascular magnetic resonance (CMR) with exercise stress testing.
Time frame: Baseline
Number of heart failure hospitalizations will be determined by the number of patients admitted to the hospital due to heart failure complications.
Time frame: Baseline
The number of cardiac deaths will include all patients whose death is attributable to a cardiac cause.
Time frame: Baseline
The number of deaths will include all patient deaths, regardless of cause.
Contact information is provided by the study sponsor or research team.
Mayo Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06081543
Cardiovascular Diseases, Heart Diseases
Columbus, Ohio, United States
View Trial DetailsNCT07202000
Heart Failure With Preserved Ejection Fraction
Boston, Massachusetts, United States
View Trial DetailsNCT07083011
Heart Failure With Preserved Ejection Fraction
Rochester, Minnesota, United States
View Trial DetailsNCT07214376
Cardiovascular Diseases, Heart Diseases
Houma, Louisiana, United States
View Trial Details